New CII Stories: A call for practitioner experiences with the hydrocodone/apap rescheduling.

New CII Stories: A call for practitioner experiences with the hydrocodone/apap rescheduling.

Today the Drug Enforcement Administration (DEA) officially rescheduled hydrocodone combination products (HCP) from Schedule III to Schedule II.  HCP’s are...

Inventory Nightmare: Hydrocodone/APAP as a CII

Inventory Nightmare: Hydrocodone/APAP as a CII

Friday the Drug Enforcement Administration (DEA) announced that effective October 6, 2014, all hydrocodone combination products (HCPs) will move from...

Attention-driven choice: DEA vs. Omnicare, Inc

Attention-driven choice: DEA vs. Omnicare, Inc

In the spring of 2012, the Drug Enforcement Administration (DEA) landed a major blow to the operations of Long Term...

All original content on these pages is fingerprinted and certified by Digiprove